252 related articles for article (PubMed ID: 26063582)
21. Lower expression of miR-218 in human breast cancer is associated with lymph node metastases, higher grades, and poorer prognosis.
Ahmadinejad F; Mowla SJ; Honardoost MA; Arjenaki MG; Moazeni-Bistgani M; Kheiri S; Teimori H
Tumour Biol; 2017 Aug; 39(8):1010428317698362. PubMed ID: 28857013
[TBL] [Abstract][Full Text] [Related]
22. Direct serum assay for microRNA-21 concentrations in early and advanced breast cancer.
Asaga S; Kuo C; Nguyen T; Terpenning M; Giuliano AE; Hoon DS
Clin Chem; 2011 Jan; 57(1):84-91. PubMed ID: 21036945
[TBL] [Abstract][Full Text] [Related]
23. Down-regulated microRNA-124 expression as predictive biomarker and its prognostic significance with clinicopathological features in breast cancer patients.
Arabkheradmand A; Safari A; Seifoleslami M; Yahaghi E; Gity M
Diagn Pathol; 2015 Sep; 10():178. PubMed ID: 26415857
[TBL] [Abstract][Full Text] [Related]
24. Upregulation of Circulating MiR-21 Expression as a Potential Biomarker for Therapeutic Monitoring and Clinical Outcome in Breast Cancer.
Anwar SL; Sari DNI; Kartika AI; Fitria MS; Tanjung DS; Rakhmina D; Wardana T; Astuti I; Haryana SM; Aryandono T
Asian Pac J Cancer Prev; 2019 Apr; 20(4):1223-1228. PubMed ID: 31030498
[TBL] [Abstract][Full Text] [Related]
25. Persistent upregulation of U6:SNORD44 small RNA ratio in the serum of breast cancer patients.
Appaiah HN; Goswami CP; Mina LA; Badve S; Sledge GW; Liu Y; Nakshatri H
Breast Cancer Res; 2011 Sep; 13(5):R86. PubMed ID: 21914171
[TBL] [Abstract][Full Text] [Related]
26. Circulating Pre-microRNA-488 in Peripheral Blood Is a Potential Biomarker for Predicting Recurrence in Breast Cancer.
Masuda T; Shinden Y; Noda M; Ueo H; Hu Q; Yoshikawa Y; Tsuruda Y; Kuroda Y; Ito S; Eguchi H; Ohno S; Mimori K
Anticancer Res; 2018 Aug; 38(8):4515-4523. PubMed ID: 30061217
[TBL] [Abstract][Full Text] [Related]
27. Prognostic implications of tissue and serum levels of microRNA-128 in human prostate cancer.
Sun X; Yang Z; Zhang Y; He J; Wang F; Su P; Han J; Song Z; Fei Y
Int J Clin Exp Pathol; 2015; 8(7):8394-401. PubMed ID: 26339409
[TBL] [Abstract][Full Text] [Related]
28. Prognostic and biological significance of microRNA-221 in breast cancer.
Eissa S; Matboli M; Sharawy A; El-Sharkawi F
Gene; 2015 Dec; 574(1):163-7. PubMed ID: 26253160
[TBL] [Abstract][Full Text] [Related]
29. Low levels of serum miR-99a is a predictor of poor prognosis in breast cancer.
Li J; Song ZJ; Wang YY; Yin Y; Liu Y; Nan X
Genet Mol Res; 2016 Aug; 15(3):. PubMed ID: 27706621
[TBL] [Abstract][Full Text] [Related]
30. A circulating miRNA signature as a diagnostic biomarker for non-invasive early detection of breast cancer.
Zhang L; Xu Y; Jin X; Wang Z; Wu Y; Zhao D; Chen G; Li D; Wang X; Cao H; Xie Y; Liang Z
Breast Cancer Res Treat; 2015 Nov; 154(2):423-34. PubMed ID: 26476723
[TBL] [Abstract][Full Text] [Related]
31. Study on the relationship between miR-520g and the development of breast cancer.
Ren GB; Wang L; Zhang FH; Meng XR; Mao ZP
Eur Rev Med Pharmacol Sci; 2016; 20(4):657-63. PubMed ID: 26957267
[TBL] [Abstract][Full Text] [Related]
32. Serum overexpression of microRNA-10b in patients with bone metastatic primary breast cancer.
Zhao FL; Hu GD; Wang XF; Zhang XH; Zhang YK; Yu ZS
J Int Med Res; 2012; 40(3):859-66. PubMed ID: 22906258
[TBL] [Abstract][Full Text] [Related]
33. Identification of Specific miRNA Signature in Paired Sera and Tissue Samples of Indian Women with Triple Negative Breast Cancer.
Thakur S; Grover RK; Gupta S; Yadav AK; Das BC
PLoS One; 2016; 11(7):e0158946. PubMed ID: 27404381
[TBL] [Abstract][Full Text] [Related]
34. Dysregulation of miR-122, miR-574 and miR-375 in Egyptian patients with breast cancer.
Elghoroury EA; Abdelghafar EE; Kamel S; Awadallah E; Shalaby A; El-Saeed GSM; Mahmoud E; Kamel MM; Abobakr A; Yousef RN
PLoS One; 2024; 19(5):e0298536. PubMed ID: 38820252
[TBL] [Abstract][Full Text] [Related]
35. A novel serum microRNA-based identification and classification biomarker of human glioma.
Xing W; Zeng C
Tumour Biol; 2017 May; 39(5):1010428317705339. PubMed ID: 28475008
[TBL] [Abstract][Full Text] [Related]
36. Investigation of microRNA-155 as a serum diagnostic and prognostic biomarker for colorectal cancer.
Lv ZC; Fan YS; Chen HB; Zhao DW
Tumour Biol; 2015 Mar; 36(3):1619-25. PubMed ID: 25528214
[TBL] [Abstract][Full Text] [Related]
37. Serum MicroRNA-370 as a potential diagnostic and prognostic biomarker for pediatric acute myeloid leukemia.
Lin X; Wang Z; Wang Y; Feng W
Int J Clin Exp Pathol; 2015; 8(11):14658-66. PubMed ID: 26823789
[TBL] [Abstract][Full Text] [Related]
38. Prognostic significance of microRNA-10b overexpression in breast cancer: a meta-analysis.
Wang N; Chen P; Huang LP; Wang TZ
Genet Mol Res; 2016 Apr; 15(2):. PubMed ID: 27173192
[TBL] [Abstract][Full Text] [Related]
39. Identification of recurrence-related microRNAs in the bone marrow of breast cancer patients.
Ota D; Mimori K; Yokobori T; Iwatsuki M; Kataoka A; Masuda N; Ishii H; Ohno S; Mori M
Int J Oncol; 2011 Apr; 38(4):955-62. PubMed ID: 21271219
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of microRNAs-29a, 92a and 145 in colorectal carcinoma as candidate diagnostic markers: An Egyptian pilot study.
Ramzy I; Hasaballah M; Marzaban R; Shaker O; Soliman ZA
Clin Res Hepatol Gastroenterol; 2015 Sep; 39(4):508-15. PubMed ID: 25736690
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]